APA (7th ed.) Citation

Tasian, S. K., Teachey, D. T., Li, Y., Shen, F., Harvey, R. C., Chen, I., . . . Grupp, S. A. (2017). Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia. Blood, 129(2), 177-187. https://doi.org/10.1182/blood-2016-05-707653

Chicago Style (17th ed.) Citation

Tasian, Sarah K., et al. "Potent Efficacy of Combined PI3K/mTOR and JAK or ABL Inhibition in Murine Xenograft Models of Ph-like Acute Lymphoblastic Leukemia." Blood 129, no. 2 (2017): 177-187. https://doi.org/10.1182/blood-2016-05-707653.

MLA (9th ed.) Citation

Tasian, Sarah K., et al. "Potent Efficacy of Combined PI3K/mTOR and JAK or ABL Inhibition in Murine Xenograft Models of Ph-like Acute Lymphoblastic Leukemia." Blood, vol. 129, no. 2, 2017, pp. 177-187, https://doi.org/10.1182/blood-2016-05-707653.